Nursing Medical News about cervical cancer screening; HPV testing

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Should primary cervical cancer screening of women 30 years and older include HPV testing?
APCToday, 06/17/09

Cox TJ - More and more, data point to cotesting as the screen of choice for women 30 years and older, with the screening interval extended to 3 years for any patient who tests negative on both HPV and Pap tests. These two important studies provide further evidence that testing for human papillomavirus (HPV) merits a prominent place in primary cervical cancer screening in developed and developing nations. Sankaranarayanan and colleagues found that a single round of HPV testing in a low-resource setting (rural India) significantly reduced the incidence of advanced cervical cancer and associated mortality. Castle and associates demonstrated that the number of HPV-positive findings among women 30 years and older was not excessive when the HPV and Pap tests were used together (cotesting). In addition, with cotesting, the screening interval for women who tested negative on both tests could be extended to 3 years.

<< Previous
The Multidimensional Burden of Hepatitis C and Its Treatment: A...

Next >>
Lemon juice as an alternative therapy in hypertension in Turkey